Cosnes J (June 2004). "Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice". Best Practice & Research. Clinical Gastroenterology. 18 (3): 481–96. doi:10.1016/j.bpg.2003.12.003. PMID15157822.
Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG (January 2012). "Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review". Gastroenterology. 142 (1): 46–54.e42, quiz e30. doi:10.1053/j.gastro.2011.10.001. PMID22001864. S2CID206223870.[pautan mati kekal]
"Innate immunity in Crohn's disease: the reverse side of the medal". Journal of Clinical Gastroenterology. 42 Suppl 3 Pt 1: S144–7. September 2008. doi:10.1097/MCG.0b013e3181662c90. PMID18806708.
"New insights into inflammatory bowel disease pathophysiology: paving the way for novel therapeutic targets". Current Drug Targets. 9 (5): 413–8. May 2008. doi:10.2174/138945008784221170. PMID18473770.
"Mycobacteria in Crohn's disease: how innate immune deficiency may result in chronic inflammation". Expert Review of Clinical Immunology. 6 (4): 633–41. July 2010. doi:10.1586/eci.10.29. PMID20594136.
Cosnes J (June 2004). "Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice". Best Practice & Research. Clinical Gastroenterology. 18 (3): 481–96. doi:10.1016/j.bpg.2003.12.003. PMID15157822.
Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG (January 2012). "Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review". Gastroenterology. 142 (1): 46–54.e42, quiz e30. doi:10.1053/j.gastro.2011.10.001. PMID22001864. S2CID206223870.[pautan mati kekal]
"Innate immunity in Crohn's disease: the reverse side of the medal". Journal of Clinical Gastroenterology. 42 Suppl 3 Pt 1: S144–7. September 2008. doi:10.1097/MCG.0b013e3181662c90. PMID18806708.
"New insights into inflammatory bowel disease pathophysiology: paving the way for novel therapeutic targets". Current Drug Targets. 9 (5): 413–8. May 2008. doi:10.2174/138945008784221170. PMID18473770.
"Mycobacteria in Crohn's disease: how innate immune deficiency may result in chronic inflammation". Expert Review of Clinical Immunology. 6 (4): 633–41. July 2010. doi:10.1586/eci.10.29. PMID20594136.
Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG (January 2012). "Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review". Gastroenterology. 142 (1): 46–54.e42, quiz e30. doi:10.1053/j.gastro.2011.10.001. PMID22001864. S2CID206223870.[pautan mati kekal]
"Inflammatory Bowel Disease"(PDF). World Gastroenterology Organization. Ogos 2015. Diarkibkan(PDF) daripada yang asal pada Mac 14, 2016. Dicapai pada Mac 13, 2016.
"Inflammatory Bowel Disease"(PDF). World Gastroenterology Organization. Ogos 2015. Diarkibkan(PDF) daripada yang asal pada Mac 14, 2016. Dicapai pada Mac 13, 2016.